MedTrace Logo

Registry Study for the Observation of Patients With ESUS/Cryptogenic Stroke

NCT03820375 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 750

Last updated 2019-01-30

No results posted yet for this study

Summary

Up to know, there is no clear diagnostic and therapeutic pathway for patients with embolic stroke of undetermined source (ESUS). This prospective registry study, which follows up adult ESUS patients for 36 months, is intended to provide important data for the detection of an individual approach in ESUS patients based on a structured diagnostic and therapeutic pathway.

Conditions

  • Embolic Stroke of Undetermined Source

Sponsors & Collaborators

  • Ludwig-Maximilians - University of Munich

    lead OTHER

Principal Investigators

  • Lars Kellert · Ludwig-Maximilians - University of Munich

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2023-01-01
Completion
2026-01-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03820375 on ClinicalTrials.gov